Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 1 Apr 2024
- Ended
- 14 Sept 2024
- Type of study
- Observational
- Treatments tested
- Prognostic biomarker as Red Cell Distribution Width
- Record updated
- 7 March 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age Group: all adult patients aged more than 18 Years old and less than 70 years old
- Intensive care unit admitted patients with sepsis
Who cannot take part
- Patients with known hematological disease (e.g., leukemia, myelodysplastic syndrome), human immunodeficiency virus (HIV) infection or any immunosuppressant usage history
- Patients having uncured malignancy
- Patients who had a cardiac arrest event before ICU arrival
- Patients less than 18 years old and more than 70 years old
- Patients who had recent (less than one week) blood transfusion
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Various biomarkers are used for predicting outcome from sepsis and septic shock, but single value doesn't give a clear-cut picture. This prospective observational study aims to approach the prognostic value of Red Cell Distribution Width for morbidity and mortality of intensive care unit patients with sepsis. and this will be achieved by:
Read full original descriptionShow less
* Assessment of prognostic value of red cell distribution width in septic intensive care unit patients for 28 days mortality * Comparison between red cell distribution width and other inflammatory markers as C-reactive protein and serum lactate as well as other scoring systems such as Sequential Organ Failure Assessment (SOFA) score, regarding their prognostic discriminative ability.
Treatments tested
- Prognostic biomarker as Red Cell Distribution Width
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Red Cell Distribution Width as a Prognostic Factor for Morbidity and Mortality of Intensive Care Unit Patients With Sepsis.
- Record updated
- 7 March 2025